Navigation Links
Achieving Optimal Performance from Single-Use Platforms, New Life Science Webinar Hosted by Xtalks
Date:3/11/2013

Toronto, Canada (PRWEB) March 11, 2013

Balancing flexibility and costs under an accelerated timeline is a challenge for any biotech firm. This webinar will describe the quality and regulatory points to consider, as well as the economic factors that support and justify expansion. Speakers from Fujifilm Diosynth Biotechnologies — a Contract Development & Manufacturing facility that has a successful history of supplying both clinical and commercial cell culture derived human therapeutics using stainless steel bioreactor platforms — will discuss the design basis for “all” single use manufacturing processes. They exploit the single use concept from ‘vial thaw through to bulk monoclonal antibody drug substance’.

The keys to maximizing the investment in a cGMP cell culture manufacturing facility and achieving operational benefits start during process development and initial process design.

This webinar will examine:

  •     The upstream and downstream development platforms that need to be modified and optimized to support efficient process definition and effective technology transfer to fully exploit single use bioprocess technologies. A case study involving Fujifilm Diosynth Biotechnologies’ cell line development will be presented.
  •     How upfront development of a robust single use process platform streamlines manufacturing operations and provides advantages in technology transfer via elegant process design
  •     How these advantages in operational robustness and process transfer efficiency allow for rapid process portability to enable manufacturing flexibility on a global scale

For more information about this event or to register, visit: http://xtks.in/xto574-event

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com/ContactUs.ashx

Contact:
Karen Lim (416) 977-6555 ext 227
clientservices(at)xtalks(dot)com

Read the full story at http://www.prweb.com/releases/2013/3/prweb10499431.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. PAREXEL Introduces Executive Briefing Series on Proven Practices to Assist Emerging and Mid-size Biopharma in Achieving Better Outcomes
2. Ian Somerhalder Raises Big Money for the Environment; Optimal Chemical Comments His Effort Proves He's a True Green Celebrity
3. Cold Adds Up to Sandy Victims' Mold Problems; Optimal Chemical Reaches Out to Help by Advising the Use of Molderizer
4. Stoneville Cotton Seed from Bayer CropScience Celebrates 90 Years of Performance
5. Bayer CropScience and MS Technologies’ Balance GT Soybean to Usher in Next Era of Performance and Weed Control
6. Elsevier and Kanazawa University in Japan Collaborate to Map Universitys Research Performance
7. New nanotech fiber: Robust handling, shocking performance
8. Thomson Reuters Online Resource Offers Key Trends in Scientific Research and Performance Analysis
9. Puritan Awarded U.S. Patent for High-Performance HydraFlock® Swab
10. Growers Choose the Bayer CropScience LibertyLinkSystem for Yield and Performance
11. Automated Online Sample Preparation Comes to Waters UltraPerformance Liquid Chromatography (UPLC) Platform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)...  In the pharmaceutical industry the medical affairs function ... activities including the identification and engagement of key thought ... high in the oncology therapeutic area where most treating ... Role of Medical Affairs in Oncology Launch Excellence ." ... find better ways to utilize medical affairs to develop ...
(Date:2/5/2016)... , February 5, 2016 ... a biotechnology company focused on developing products for Regenerative ... requested Rare Pediatric Disease Designation (RPDD) from the US ... (RP) with MANF. MANF was previously granted orphan drug ... --> Amarantus BioScience Holdings, Inc. ...
(Date:2/4/2016)... (PRWEB) , ... February 04, 2016 , ... ... talent development and compliance training, today announced an interactive FDA compliance training ... The RAPS (Regulatory Affairs Professional Society) accredited interactive course on Morf Playbook—now ...
(Date:2/4/2016)... Calif. , Feb. 4, 2016  Sangamo BioSciences, ... genome editing, announced today that Edward Lanphier , ... update on the progress of Sangamo,s ZFP Therapeutic ® ... business strategy at 2:40 pm ET on Thursday, February ... Annual Global Healthcare Conference. The conference is being held ...
Breaking Biology Technology:
(Date:1/8/2016)... LOS ANGELES and MANCHESTER, United Kingdom ... ("BBI"), a developer of innovative sensor-based diagnostic products, today ... was financed by new and existing investors.  Proceeds from the ... SEM Scanner , a hand-held device for detecting early-stage ... and Ireland after receiving CE Mark ...
(Date:1/7/2016)... -- This BCC Research report studies the global as ... identifying newer markets and exploring the expansion of the ... Includes forecast from 2015 to 2020. Use ... the expansion of the present application market for various ... technology, determine its current market size, and estimate the ...
(Date:1/7/2016)...  A United States District Court in ... country to interpret a biometric privacy statute in a ... the photo website Shutterfly brought by the law firm Carey ... vs. SHUTTERFLY, INC.; and THISLIFE, INC ( N.D. Ill ... the Illinois Biometric Privacy Act by collecting and scanning ...
Breaking Biology News(10 mins):